Tag: CaaMTech - Psychedelic Alpha

Our 2022 Year in Review is now live.

Read more about the article CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction

CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction

Post published:November 16, 2021
Post category:Press Release

Read more about the article CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

Post published:September 8, 2021
Post category:Press Release

Read more about the article Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Post published:February 10, 2021
Post category:Press Release

Read more about the article Andrew Chadeayne, Founder and CEO of CaaMTech

Andrew Chadeayne, Founder and CEO of CaaMTech

Post published:December 10, 2020
Post category:Interview

Read more about the article CaaMTech Expands Successful Next-Gen Drug Research Collaboration with UMass Dartmouth

CaaMTech Expands Successful Next-Gen Drug Research Collaboration with UMass Dartmouth

Post published:December 9, 2020
Post category:Press Release

Read more about the article CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms

CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms

Post published:December 1, 2020
Post category:Press Release

Read more about the article CaaMTech Researchers Synthesize and Structurally Characterize Deprocin Hydrochloride

CaaMTech Researchers Synthesize and Structurally Characterize Deprocin Hydrochloride

Post published:November 30, 2020
Post category:Press Release

Read more about the article CaaMTech Synthesizes Novel Tryptamine Prophoria™, Amphoria™

CaaMTech Synthesizes Novel Tryptamine Prophoria™, Amphoria™

Post published:July 7, 2020
Post category:Press Release

Read more about the article Interview with CaaMTech

Interview with CaaMTech

Post published:April 28, 2020
Post category:Interview

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.